Trials / Unknown
UnknownNCT05818176
To Improve the Clinical Outcome of Ultrasound-guided Radiofrequency Ablation by NAVIRFA® Navigation System.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- National Taiwan University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Ultrasonic-guided radiofrequency ablation is the most common minimally invasive treatment for liver cancer. This study will use my country's self-developed intelligent ultrasonic navigation tool (NAVIRFA® Navigation System) to assist in the puncture of the needle during ablation, to observe the operation time, Whether the needle accuracy, ablation effect and complications are different from the traditional free-hand ultrasonic guidance technology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NAVIRFA® Navigation System | radiofrequency ablation by NAVIRFA® Navigation System. |
| DEVICE | ultrasound | radiofrequency ablation by ultrasound |
Timeline
- Start date
- 2023-04-01
- Primary completion
- 2023-06-30
- Completion
- 2023-12-31
- First posted
- 2023-04-18
- Last updated
- 2023-04-18
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05818176. Inclusion in this directory is not an endorsement.